-
Je něco špatně v tomto záznamu ?
SCORE2 Screening Tool for Cardiovascular Risk Assessment in Psoriasis-A Case-Control Study
T. Kampe, J. Baloghová, P. Kolarčik, K. Rimárová, E. Dorko
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
This work was supported by grants KEGA 008UPJŠ-4/2020; 010UPJŠ-4/2021; 003UPJŠ-4/2024 and 001UPJŠ-4/2024- All 4 KEGA grants represent financial support from of the Ministry of Education, Science, Research and Sport of the Slovak Republic.
Ministry of Education, Science, Research and Sport of the Slovak Republic
NLK
Free Medical Journals
od 2012
PubMed Central
od 2012
Europe PubMed Central
od 2012
ProQuest Central
od 2019-01-01
Open Access Digital Library
od 2012-01-01
Open Access Digital Library
od 2012-01-01
Health & Medicine (ProQuest)
od 2019-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2012
PubMed
38892947
DOI
10.3390/jcm13113237
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Background: Psoriasis is a common, T-cell-mediated inflammatory and immune-mediated skin disease. Numerous studies confirmed that patients with psoriasis have a significant frequency of cardiovascular (CV) risk factors and CV diseases (CVDs). Risk stratification is helpful in light of the elevated risk of CVD in psoriasis patients. SCORE2 and SCORE2-OP, a new algorithm derived, calibrated and validated to predict the 10-year risk of first-onset CVD in European populations, enhances the identification of individuals at higher risk of developing CVD across Europe. Objective: Using the SCORE2 and SCORE2-OP scoring systems, the current study objective was to evaluate CV risk in Slovak psoriasis patients and the relationship between CV risk and psoriasis features in a real-world setting. Results: A case-control study was conducted involving 115 outpatients with plaque psoriasis and 66 age- and gender-matched controls with skin conditions other than psoriasis. Patients with psoriasis had significantly higher mean SCORE2 values. In the age group up to 50 years, more psoriasis patients were classified as moderate risk than controls (33.8% vs. 13.6%, p = 0.010); the high-risk category was dominated by psoriasis patients. Analysing the relationship between CV risk and selected variables, we determined, using linear regression, the dependence of the SCORE2 risk score on gender in the age group up to 50 years, on age in both age groups, on waist circumference (WC) in the category up to 50 years and on the duration and severity of psoriasis in both age groups using linear regression. For individuals older than 70, we estimated the SCORE2-OP risk score, with the average risk score being 19.5 ± 4.95. We did not observe controls with a high risk score. Psoriasis patients were more likely to be smokers and had significantly higher mean values for body mass index (BMI), WC, total cholesterol (TC), low-density lipoprotein (LDL) and systolic blood pressure (BP). Conclusions: Because CV risk factors and psoriasis are strongly related, the importance of CV risk stratification is growing, and initiating preventive lifestyle changes or therapeutic interventions in patients with psoriasis is warranted.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24012669
- 003
- CZ-PrNML
- 005
- 20240726151339.0
- 007
- ta
- 008
- 240723s2024 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/jcm13113237 $2 doi
- 035 __
- $a (PubMed)38892947
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Kampe, Tomáš $u Department of Dermatovenerology, Faculty of Medicine, University Hospital, P. J. Safarik University, 040 01 Kosice, Slovakia
- 245 10
- $a SCORE2 Screening Tool for Cardiovascular Risk Assessment in Psoriasis-A Case-Control Study / $c T. Kampe, J. Baloghová, P. Kolarčik, K. Rimárová, E. Dorko
- 520 9_
- $a Background: Psoriasis is a common, T-cell-mediated inflammatory and immune-mediated skin disease. Numerous studies confirmed that patients with psoriasis have a significant frequency of cardiovascular (CV) risk factors and CV diseases (CVDs). Risk stratification is helpful in light of the elevated risk of CVD in psoriasis patients. SCORE2 and SCORE2-OP, a new algorithm derived, calibrated and validated to predict the 10-year risk of first-onset CVD in European populations, enhances the identification of individuals at higher risk of developing CVD across Europe. Objective: Using the SCORE2 and SCORE2-OP scoring systems, the current study objective was to evaluate CV risk in Slovak psoriasis patients and the relationship between CV risk and psoriasis features in a real-world setting. Results: A case-control study was conducted involving 115 outpatients with plaque psoriasis and 66 age- and gender-matched controls with skin conditions other than psoriasis. Patients with psoriasis had significantly higher mean SCORE2 values. In the age group up to 50 years, more psoriasis patients were classified as moderate risk than controls (33.8% vs. 13.6%, p = 0.010); the high-risk category was dominated by psoriasis patients. Analysing the relationship between CV risk and selected variables, we determined, using linear regression, the dependence of the SCORE2 risk score on gender in the age group up to 50 years, on age in both age groups, on waist circumference (WC) in the category up to 50 years and on the duration and severity of psoriasis in both age groups using linear regression. For individuals older than 70, we estimated the SCORE2-OP risk score, with the average risk score being 19.5 ± 4.95. We did not observe controls with a high risk score. Psoriasis patients were more likely to be smokers and had significantly higher mean values for body mass index (BMI), WC, total cholesterol (TC), low-density lipoprotein (LDL) and systolic blood pressure (BP). Conclusions: Because CV risk factors and psoriasis are strongly related, the importance of CV risk stratification is growing, and initiating preventive lifestyle changes or therapeutic interventions in patients with psoriasis is warranted.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Baloghová, Janette $u Department of Dermatovenerology, Faculty of Medicine, University Hospital, P. J. Safarik University, 040 01 Kosice, Slovakia $1 https://orcid.org/0000000344705777
- 700 1_
- $a Kolarčik, Peter $u Department of Health Psychology and Research Methodology, Faculty of Medicine, P. J. Safarik University, 040 01 Kosice, Slovakia $u Olomouc University Social Health Institute, Palacky University Olomouc, 779 00 Olomouc, Czech Republic $1 https://orcid.org/0000000345045256
- 700 1_
- $a Rimárová, Kvetoslava $u Department of Public Health and Hygiene, Faculty of Medicine, P. J. Safarik University, 040 01 Kosice, Slovakia $1 https://orcid.org/0000000343640553
- 700 1_
- $a Dorko, Erik $u Department of Public Health and Hygiene, Faculty of Medicine, P. J. Safarik University, 040 01 Kosice, Slovakia
- 773 0_
- $w MED00195462 $t Journal of clinical medicine $x 2077-0383 $g Roč. 13, č. 11 (2024)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38892947 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240723 $b ABA008
- 991 __
- $a 20240726151331 $b ABA008
- 999 __
- $a ok $b bmc $g 2125441 $s 1224532
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 13 $c 11 $e 20240530 $i 2077-0383 $m Journal of clinical medicine $n J Clin Med $x MED00195462
- GRA __
- $a This work was supported by grants KEGA 008UPJŠ-4/2020; 010UPJŠ-4/2021; 003UPJŠ-4/2024 and 001UPJŠ-4/2024- All 4 KEGA grants represent financial support from of the Ministry of Education, Science, Research and Sport of the Slovak Republic. $p Ministry of Education, Science, Research and Sport of the Slovak Republic
- LZP __
- $a Pubmed-20240723